UBQLN4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.77220493624964E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.88149956620509E-10 |
Normal-vs-Stage2 |
1.54799999485533E-08 |
Normal-vs-Stage3 |
3.06460412602405E-11 |
Normal-vs-Stage4 |
1.16649999659657E-08 |
Stage1-vs-Stage2 |
3.338800E-01 |
Stage1-vs-Stage3 |
1.689630E-01 |
Stage1-vs-Stage4 |
8.922600E-01 |
Stage2-vs-Stage3 |
9.679200E-01 |
Stage2-vs-Stage4 |
3.850400E-01 |
Stage3-vs-Stage4 |
2.507600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.86409784777675E-11 |
Normal-vs-AfricanAmerican |
7.65340000041803E-07 |
Normal-vs-Asian |
2.605200E-01 |
Caucasian-vs-AfricanAmerican |
3.339600E-01 |
Caucasian-vs-Asian |
6.674000E-02 |
AfricanAmerican-vs-Asian |
1.670600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.30629967848495E-11 |
Normal-vs-Female |
8.90760021299286E-10 |
Male-vs-Female |
2.471000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.504800E-03 |
Normal-vs-Age(41-60Yrs) |
2.92540436319655E-11 |
Normal-vs-Age(61-80Yrs) |
3.58310048298449E-10 |
Normal-vs-Age(81-100Yrs) |
3.76479999997237E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.744200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.165800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.253600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.034000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.158000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.975400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.036800E-03 |
Normal-vs-Grade 2 |
1.50540024890233E-10 |
Normal-vs-Grade 3 |
2.14960271804898E-11 |
Normal-vs-Grade 4 |
4.50769999993383E-07 |
Grade 1-vs-Grade 2 |
2.197400E-01 |
Grade 1-vs-Grade 3 |
1.384010E-01 |
Grade 1-vs-Grade 4 |
5.805000E-01 |
Grade 2-vs-Grade 3 |
4.087600E-01 |
Grade 2-vs-Grade 4 |
2.186600E-01 |
Grade 3-vs-Grade 4 |
7.804500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.15210063711402E-11 |
Normal-vs-ccB subtype |
4.9980997118837E-10 |
ccA subtype-vs-ccB subtype |
2.006000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.01250152495913E-11 |
Normal-vs-N1 |
8.967400E-01 |
N0-vs-N1 |
4.169700E-02 |
|
|